The Fred Hutch Bone Marrow Transplant Program at Seattle Cancer Care Alliance (SCCA) consistently ranks among the country’s top transplant centers, and our doctors have performed more than 15,000 transplants—more than any other institution in the world.
Call (800) 804-8824 or (206) 606-1024 to refer a patient, arrange a transplant telephone consultation, or make an appointment for your patient to see one of our transplant specialists.
Partnering with referring doctors and staying in close contact about our shared patients leads to the best transplant results. Together, we make more cures possible.
Why choose SCCA for a bone marrow transplant?
Excellent transplant outcomes
Ours is one of only five transplant centers nationwide whose patients achieved higher-than-expected survival rates for the last four consecutive years, according to a study by the Center for International Blood and Marrow Transplant Research.
Promising options for more candidates
More patients are eligible for transplant than ever before, thanks to the wide range of options available at SCCA, including innovations like:
- Reduced-intensity (non-myeloablative) conditioning for older patients or those with comorbidities
- Cord blood or minimally mismatched or haploidentical transplants so nearly everyone has a donor
- Transplant clinical trials testing the latest regimens
Well-developed support for transplant patients
We have extensive experience supporting patients and families before, during, and after transplant with resources such as housing options, school and childcare, caregiver training and support and help with financial arrangements and insurance.
Long-term transplant follow-up
SCCA’s Long-Term Follow-Up Program for transplant recipients is unmatched. Our highly trained transplant specialists provide lifelong services—including telephone consultations and direct care—to patients and their doctors to prevent, manage, and treat late effects and graft-versus-host-disease and consider alternatives for those whose disease recurs.
The future of transplantation is here
Fred Hutch teams first developed clinical use of bone marrow transplants more than 40 years ago, under the direction of E. Donnall Thomas, MD, who won a Nobel Prize for his groundbreaking work.
Today, we are advancing use of stem cell transplantation for a broader array of diseases—not only leukemia, Hodgkin’s and non-Hodgkin’s lymphoma, and multiple myeloma, but also other cancers, bone marrow deficiencies, inborn errors of metabolism and immune disorders.
Learn more about our transplant program.